* The production site is located in National Level Industry Zone in Taizhou City, Zhejiang Province.

* We established robust quality system and has passed FDA, WHO, EDQM, ANVISA and NMPA' s on-site inspections.  3 US-DMF has been filed, 2 EU GMP and 4 CEP were granted. 

* Excellent EHS system to support supply sustainability. The EHS system has passed PSCI and many big pharma' s inspections. 

* With the collaborating of R&D Centers and Taizhou site, we provide the integrated small molecule solutions, from GLP Tox , Clinical Phase, to commercial supply with the scale of gram, KG to Tons.   

* Langhua has a flexible, project-driven approach to customers' request, targeting a custom-made solution fit for your purpose and requirements. With the experienced project manage team, Langhua commits to deliver the project on time, on budget and to the expected quality standard.

* To meet the capacity needs of fast-growing CDMO projects, Langhua will invest 150 Million dollars to build 4 state-of-the-art multifunction workshops within next 3 years. The new investment will increase the total reactor volume to 3000 M³. 

* We have 1000 M³ reactor volume, from 50 L to 12000 L various material reactors, including 200L, 800L and 1500 L GMP hydrogenation reactors, can handle various reactions including low temperature( -80 ℃)  ,  high temperature (250 ℃) ，and  high-pressure (up to 9.9 Mpa).